Rise in Lung Cancer Among Non-Smoking Women and Cancer Trends in Belgium

More than 215 Belgians are informed of a cancer diagnosis every day. While the national volume of new cases is climbing, a specific and troubling trend has emerged: a rise in lung cancer among non-smokers, with a particularly notable increase among women.

Medical professionals are observing the pattern, yet the precise causes for this surge in non-smoking women remain unknown. It is a clinical shift that defies traditional risk factors.

The Case of the Healthy Patient

Tamara is 55 years old. Her life was defined by daily exercise and healthy living, yet she developed lung cancer. As reported by HBVL, her experience is not an isolated incident; it underscores a growing pattern where tobacco use is entirely absent from an increasing number of diagnoses.

78,000 New Diagnoses in 2024

The scale of the crisis is stark. According to Knack, there are more than 78,000 new cancer diagnoses in Belgium for the year 2024. This volume places the rise of non-smoking lung cancer within a broader context of increasing prevalence across the general population.

The burden is not shared equally across the map.

A Shift in the Demographic Profile

Historically, lung cancer was tethered to smoking rates. That link is fracturing. The current trend reported by HBVL indicates that other variables—not yet fully understood by the medical community—are now playing a role in the disease’s demographic profile.

New Therapies and Patient Outcomes

There is a counter-narrative to the rising numbers: the prognosis is shifting. De Standaard reports that lung cancer is becoming more treatable, stating that “new treatments are making a real difference in patient outcomes.”

By integrating these new therapies, clinicians can target the disease more effectively. For many, this provides a more realistic chance of recovery or extended survival than previous standard care protocols provided.